Optimal clinical trial design using value of information methods with imperfect implementation.

Area of Science:

• Biostatistics
• Clinical Trial Design
• Health Economics

Background:

• Traditional sample size calculations rely on hypothesis testing and arbitrary factors like error rates.
• Value of information methods offer an alternative but often assume perfect implementation of trial findings.
• Previous models did not account for the complexities of real-world intervention adoption.

Purpose of the Study:

• To propose a novel framework for sample size calculations that relaxes the assumption of perfect implementation.
• To assess the impact of imperfect implementation on optimal sample size and expected net gain in clinical trials.
• To introduce a model for evaluating the value of implementation strategies.

Main Methods:

• Developed a flexible framework for sample size calculation incorporating imperfect implementation.
• Applied the framework to two recent clinical trial examples to illustrate its effects.
• Proposed and demonstrated a model for assessing the economic value of implementation strategies.

Main Results:

• Relaxing the perfect implementation assumption significantly affects optimal sample size and expected net gain.
• Illustrative examples demonstrate the practical implications of the proposed framework.
• The value of implementation strategies can be quantitatively assessed.

Conclusions:

• The proposed framework provides a more realistic approach to sample size determination in clinical trials.
• Considering imperfect implementation is crucial for accurate estimation of research value and resource allocation.
• This work offers a valuable tool for optimizing clinical trial design and implementation planning.